All News

Gunda Siska, PharmD, explains potential vitamins to keep patients healthy.

One of the results from the survey showed that 42% of American people do not wash their hands every time they use the restroom.

In addition, RUCDR has submitted an emergency use authorization request for a saliva collection method that will allow for broader population screening.

What was the initial reason that Detroit pharmacist James Vernor created the ginger ale, Vernors?

Camber Pharmaceuticals has announced that it has added Glycerin Liquid and 3 syrups to their increasingly diverse portfolio: Simple Syrup, Cherry Syrup and SoSweet® Syrup.

The state attorney general’s office and its State Board of Medical Examiners are limiting pharmacists and physicians from allowing patients to use certain medications for COVID-19.

The FDA has approved coagulation factor VIIA (recombinant)-jncw (Sevenfact, LFB) for the treatment and control of bleeding episodes occurring in adolescents aged 12 years and older with hemophilia A or B with inhibitors.

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.

The USP has developed an online toolkit using guidelines from major public health organizations.

Today we’re celebrating the work of Mayank Amin, PharmD, RPh, MBA, owner of Skippack Pharmacy.

Pharmacists push against state-level limits on dispensing of hydroxychloroquine for coronavirus disease 2019.

Hospitals can apply at no cost to locate and trade critical supplies to help ease drug shortages during the pandemic.

PBMI informs, advises, and influences the industry on drug cost management.

One of the critical barriers surrounding the coronavirus disease 2019 (COVID-19) pandemic is the lack of access to testing, specifically among high-risk populations.

More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what physicians typically recommend for chronic pain relief via data from clinical studies, according to research published in PLOS ONE.

According to a recent study in the Heart journal, regular tub bathing is linked to a lower risk of death from heart disease and stroke.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.

RedHill Biopharma Ltd today announced that it has completed the recently announced acquisition of the global rights to Movantik (naloxegol) for the treatment of opioid-induced constipation (OIC) from AstraZeneca.

Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.

The Department of Health and Human Services said that there are only 5 locations out of 67,000 pharmacy sites with the capacity to test for COVID-19 through the Community-Based Testing Site program.

Today’s pharmacy hero is Shawn Hodges, PharmD, of Innovation Compounding Pharmacy in Kennesaw, Georgia.

Rural community pharmacies evolve to continue serving low-income patients with chronic conditions during the coronavirus disease 2019 pandemic.

The announcement is in response to ongoing reports of contamination with N-Nitrosodimethylamine (NDMA).

The collaboration will combine VBI’s viral vaccine experience and coronavirus antigens with the NRC’s unique COVID-19 antigens and assay development capabilities.

The FDA has announced that it is accelerating the development of potentially safe and effective life-saving treatments for patients with the coronavirus 2019 disease.

New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.

Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.

Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.

Study shows rivaroxaban (Xarelto, Bayer) following nonmajor orthopedic surgery reduced the risk of major venous thromboembolism by approximately 75% compared with enoxaparin.